Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 3 | 2021 | 280 | 0.800 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2019 | 154 | 0.760 |
Why?
|
| Breast Neoplasms | 9 | 2020 | 1036 | 0.710 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 65 | 0.680 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 186 | 0.600 |
Why?
|
| Retinoblastoma Protein | 3 | 2012 | 34 | 0.570 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2015 | 459 | 0.550 |
Why?
|
| Cell Proliferation | 2 | 2017 | 884 | 0.500 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 48 | 0.500 |
Why?
|
| Gene Expression Profiling | 7 | 2019 | 684 | 0.490 |
Why?
|
| Signal Transduction | 8 | 2019 | 2689 | 0.460 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 48 | 0.460 |
Why?
|
| Brain Neoplasms | 2 | 2011 | 230 | 0.390 |
Why?
|
| Carcinoma | 1 | 2011 | 112 | 0.390 |
Why?
|
| Apoptosis | 3 | 2012 | 978 | 0.380 |
Why?
|
| Genes, Retinoblastoma | 2 | 2005 | 4 | 0.330 |
Why?
|
| Neoplasms | 3 | 2022 | 1058 | 0.300 |
Why?
|
| beta Catenin | 2 | 2017 | 84 | 0.290 |
Why?
|
| Animals | 19 | 2020 | 17732 | 0.290 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1498 | 0.260 |
Why?
|
| Mice | 12 | 2020 | 9096 | 0.260 |
Why?
|
| Neoplastic Stem Cells | 3 | 2015 | 189 | 0.260 |
Why?
|
| Epithelial Cells | 3 | 2021 | 344 | 0.260 |
Why?
|
| Transcription Factors | 4 | 2013 | 1356 | 0.240 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2022 | 14 | 0.230 |
Why?
|
| Breast | 1 | 2004 | 165 | 0.230 |
Why?
|
| Shigella | 1 | 2021 | 8 | 0.220 |
Why?
|
| Dysentery, Bacillary | 1 | 2021 | 13 | 0.220 |
Why?
|
| Chemotactic Factors | 1 | 2021 | 26 | 0.220 |
Why?
|
| Female | 15 | 2020 | 26343 | 0.210 |
Why?
|
| Drosophila melanogaster | 3 | 2006 | 471 | 0.210 |
Why?
|
| Receptors, Growth Factor | 2 | 1998 | 17 | 0.210 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 82 | 0.210 |
Why?
|
| Drosophila | 2 | 2002 | 426 | 0.200 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 76 | 0.200 |
Why?
|
| Inactivation, Metabolic | 1 | 2020 | 12 | 0.200 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 84 | 0.200 |
Why?
|
| Selenium | 1 | 2020 | 20 | 0.200 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 153 | 0.190 |
Why?
|
| Phenotype | 5 | 2014 | 996 | 0.190 |
Why?
|
| Drosophila Proteins | 3 | 2006 | 664 | 0.180 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 51 | 0.180 |
Why?
|
| Genes, ras | 2 | 2012 | 29 | 0.180 |
Why?
|
| Neutrophils | 1 | 2021 | 332 | 0.180 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 1998 | 28 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 1114 | 0.180 |
Why?
|
| Transcriptome | 2 | 2019 | 287 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2008 | 1388 | 0.170 |
Why?
|
| Liver Transplantation | 1 | 2021 | 196 | 0.170 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2017 | 5 | 0.170 |
Why?
|
| Insect Proteins | 1 | 1998 | 76 | 0.170 |
Why?
|
| Cluster Analysis | 3 | 2014 | 236 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 2 | 2015 | 59 | 0.160 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 331 | 0.160 |
Why?
|
| Wnt Proteins | 1 | 2017 | 89 | 0.160 |
Why?
|
| Receptors, Progesterone | 3 | 2012 | 106 | 0.160 |
Why?
|
| Cell Survival | 2 | 2020 | 528 | 0.160 |
Why?
|
| Mice, Knockout | 3 | 2019 | 1873 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 670 | 0.150 |
Why?
|
| Cytoplasm | 1 | 2017 | 257 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 496 | 0.150 |
Why?
|
| Genes, Insect | 4 | 2002 | 88 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 2 | 2012 | 42 | 0.140 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 8 | 0.140 |
Why?
|
| Receptor, ErbB-2 | 2 | 2012 | 48 | 0.140 |
Why?
|
| Mammary Glands, Animal | 2 | 2012 | 76 | 0.140 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 18 | 0.130 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 423 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 60 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 2857 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2019 | 755 | 0.120 |
Why?
|
| Rats | 1 | 2017 | 1676 | 0.120 |
Why?
|
| Mutation | 4 | 2021 | 2190 | 0.120 |
Why?
|
| Integrin alpha6beta1 | 1 | 2013 | 33 | 0.120 |
Why?
|
| Humans | 17 | 2021 | 49675 | 0.120 |
Why?
|
| Autocrine Communication | 1 | 2013 | 32 | 0.120 |
Why?
|
| Neuropilin-2 | 1 | 2013 | 33 | 0.120 |
Why?
|
| Pregnancy | 2 | 2017 | 2089 | 0.120 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 5 | 0.110 |
Why?
|
| Computational Biology | 1 | 2014 | 295 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 68 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 31 | 0.110 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2012 | 30 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1787 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2012 | 66 | 0.110 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 35 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2012 | 237 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2011 | 70 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 277 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2012 | 179 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 217 | 0.100 |
Why?
|
| Disease Progression | 2 | 2019 | 718 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 277 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2008 | 58 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 1249 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 110 | 0.080 |
Why?
|
| Integrin beta4 | 1 | 2008 | 30 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2020 | 215 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2002 | 159 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 750 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 56 | 0.080 |
Why?
|
| Male | 6 | 2021 | 23140 | 0.070 |
Why?
|
| Astrocytoma | 1 | 2005 | 10 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 75 | 0.070 |
Why?
|
| Genetic Engineering | 1 | 2005 | 101 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 146 | 0.060 |
Why?
|
| Sphingosine | 1 | 2022 | 21 | 0.060 |
Why?
|
| Sphingolipids | 1 | 2022 | 21 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2022 | 49 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 398 | 0.060 |
Why?
|
| Serine | 1 | 2022 | 82 | 0.060 |
Why?
|
| Lipogenesis | 1 | 2022 | 62 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2002 | 162 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2021 | 48 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2021 | 28 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 28 | 0.050 |
Why?
|
| Activin Receptors | 2 | 1998 | 11 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 364 | 0.050 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2020 | 6 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 1998 | 275 | 0.050 |
Why?
|
| Selenocysteine | 1 | 2020 | 14 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2020 | 20 | 0.050 |
Why?
|
| Intestines | 1 | 2021 | 141 | 0.050 |
Why?
|
| Selenium Compounds | 1 | 2020 | 29 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 295 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 160 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 821 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 224 | 0.050 |
Why?
|
| Cell Movement | 1 | 2021 | 386 | 0.050 |
Why?
|
| Middle Aged | 4 | 2021 | 13451 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2005 | 668 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2019 | 82 | 0.050 |
Why?
|
| Neuromuscular Diseases | 1 | 1998 | 17 | 0.040 |
Why?
|
| Frameshifting, Ribosomal | 1 | 1998 | 7 | 0.040 |
Why?
|
| Wings, Animal | 1 | 1998 | 18 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1998 | 20 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1233 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 52 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 136 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1998 | 97 | 0.040 |
Why?
|
| Larva | 1 | 1998 | 127 | 0.040 |
Why?
|
| Introns | 1 | 1998 | 100 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 123 | 0.040 |
Why?
|
| Temperature | 1 | 1998 | 280 | 0.040 |
Why?
|
| Prognosis | 2 | 2012 | 1251 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 275 | 0.040 |
Why?
|
| Insect Hormones | 1 | 1995 | 11 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2015 | 6 | 0.040 |
Why?
|
| Proteins | 2 | 1998 | 707 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2015 | 42 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1998 | 718 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1002 | 0.030 |
Why?
|
| Adult | 3 | 2019 | 13334 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 1500 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 1886 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 7 | 0.030 |
Why?
|
| Cytogenetics | 1 | 2012 | 8 | 0.030 |
Why?
|
| Karyotyping | 1 | 2012 | 40 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 59 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 401 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 30 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2012 | 139 | 0.030 |
Why?
|
| Integrases | 1 | 2012 | 30 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2012 | 35 | 0.030 |
Why?
|
| Exons | 1 | 2012 | 181 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 199 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 483 | 0.030 |
Why?
|
| Transfection | 2 | 2008 | 614 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 293 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 297 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 281 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 428 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 42 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 99 | 0.020 |
Why?
|
| Keratin-6 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Keratin-5 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2008 | 121 | 0.020 |
Why?
|
| Crosses, Genetic | 2 | 1998 | 98 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 358 | 0.020 |
Why?
|
| Species Specificity | 1 | 2007 | 310 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2008 | 354 | 0.020 |
Why?
|
| Head | 1 | 2006 | 41 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 811 | 0.020 |
Why?
|
| Body Patterning | 1 | 2006 | 76 | 0.020 |
Why?
|
| Base Sequence | 2 | 1998 | 1253 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 256 | 0.020 |
Why?
|
| Cell Death | 1 | 2006 | 248 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 231 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2006 | 309 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 587 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 1998 | 4 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1998 | 7 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1998 | 29 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 4220 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1998 | 52 | 0.010 |
Why?
|
| Homozygote | 1 | 1998 | 109 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1998 | 79 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1998 | 79 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 337 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 456 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1998 | 95 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 280 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 26 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 36 | 0.010 |
Why?
|
| Multigene Family | 1 | 1995 | 92 | 0.010 |
Why?
|
| Gene Expression | 1 | 1998 | 755 | 0.010 |
Why?
|
| Fertilization | 1 | 1995 | 86 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1995 | 147 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 10870 | 0.010 |
Why?
|
| DNA | 1 | 1995 | 695 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 1919 | 0.010 |
Why?
|